H
elicobacter pylori is a Gram-negative bacterium that frequently and chronically colonizes the human gastric mucosa. H. pylori's capacity to cause chronic infection stems from its ability to modulate the gastric immune response. Recent data demonstrate that H. pylori upregulates the production of antiinflammatory T-regulatory (Treg) cells in the stomach, thereby decreasing the inflammatory response against the bacteria. 1 In fact, H. pylori-colonized patients express higher levels of gastric Foxp3, a Treg cell marker. 2 Whether this upregulation affects systemic immune responses in addition to the local response against H. pylori is unknown. However, colonization with H. pylori has been inversely associated with certain chronic inflammatory diseases, such as asthma and lupus. 3 This suggests that immune regulation by H. pylori may have systemic effects.
Inflammatory bowel disease (IBD) is a chronic inflammatory condition of the intestinal tract, resulting in part from a dysregulated immune response. Previous work in animal models has illustrated the importance of Treg cells in the pathogenesis of colitis. For example, mice deficient in IL-10, a key regulatory cytokine of Treg cells, develop spontaneous colitis. 4 Additionally, adoptive transfer of Treg cells can inhibit the development of colitis in certain animal models. [5] [6] [7] Furthermore, a meta-analysis of studies investigating the relation between H. pylori colonization and IBD found a significant inverse association between the two, suggesting a possible protective role for H. pylori 8 colonization against the development of IBD. However, these clinical data have various confounders, limiting the certainty of the findings.
In this study we aimed to examine the effect of H. pylori on an experimental model of colitis and further define the relationship between H. pylori and IBD. We used the Salmonella typhimurium model of colitis in order Additional supporting information may be found in the online version of this article.
to illustrate the effect of gastric H. pylori colonization on a distant bacterial-host immune system interaction in the colon. 9 We found that H. pylori infection decreased cecal inflammatory cytokine expression in response to S. typhimurium infection. We also found that prior H. pylori infection influences distal mucosal immune responses, as evidenced by an increased interleukin (IL)-10 expression measured in the mesenteric lymph nodes of mice infected with H. pylori. Our data provide the first evidence that H. pylori infection in the stomach alters the immunological environment of the lower gastrointestinal (GI) tract, providing mechanistic support for the epidemiological observation of a negative association between H. pylori status and risk of IBD.
MATERIALS AND METHODS

Mice
Female 8-12-week-old C57/BL6 mice (Jackson Laboratories, Bar Harbor, ME) were infected with either H. pylori SS1, S. typhimurium DaroA or H. pylori SS1 þ S. typhimurium DaroA. Twenty-four hours prior to oral infection with 3 Â 10 6 colony-forming units (CFU) of S. typhimurium strain DaroA in 100 lL 0.1 M HEPES buffer (pH ¼ 8.0), mice received 20 mg of streptomycin in 0.1 M Hank's balanced salt solution (HBSS) by oral gavage. All animal experiments were conducted with the approval and oversight of the University of Michigan UCUCA (University Committee on Use and Care of Animals).
Bacterial Strains
Salmonella typhimurium strain DaroA (a gift from Guntram Grassl, University of British Columbia, Vancouver, BC, Canada) which is naturally resistant to streptomycin was grown in LB broth containing 100 lg/mL streptomycin at 37 C. The mouse-adapted H. pylori SS1 strain (a gift from Kathryn Eaton, University of Michigan, Ann Arbor, MI) was grown on Campylobacter-selective agar (BD Diagnostics, Bedford, MA) supplemented with 5% sterile horse blood, trimethoprim (5 lg/mL), vancomycin (10 lg/mL), and nystatin (10 lg/mL) for 2 days at 37 C in a humidified microaerophilic chamber (BBL Gas System, with CampyPak Plus packs; BD Microbiology, Sparks, MD).
Animal Studies
Mice were infected with H. pylori SS1 with an oral gavage of 10 8 CFU of live organisms thrice over 1 week. Control animals received HBSS by oral gavage. Thirty-four days after the H. pylori infection, half of the H. pyloriinfected animals (H. pylori/S. typhimurium) received 20 mg streptomycin by oral gavage followed by infection with 3 Â 10 6 CFU S. typhimurium DaroA in 100 k 0.1 M HEPES buffer (pH ¼ 8.0) (Supporting Fig. 1 ). The other half of the H. pylori-infected cohort (H. pylori group) was not infected with S. typhimurium but received streptomycin and HBSS on the same schedule. Of the animals uninfected with H. pylori, half received streptomycin and subsequent S. typhimurium infection (S. typhimurium group). Negative control (HBSS group) animals were not infected with S. typhimurium but received streptomycin and HBSS. Mice were euthanized 21 days post S. typhimurium infection.
Gross Pathology and Tissue Collection
Mice were euthanized at 21 days post-S. typhimurium infection. Cecum and distal colon were collected, photographed, measured, and weighed. Cecal area was determined from digital photographs using ImageJ (NIH, Bethesda, MD) and a defined region of interest (ROI) to delineate the cecum. To control for differences in images, the cecal area was normalized against a 1-cm marker in the photographic image. Tissues were snap-frozen in liquid nitrogen and stored at À80 C prior to molecular analysis. Cecal contents were collected and serially diluted before plating onto LBstreptomycin plates to determine bacterial titers.
Histology
Formalin-fixed and paraffin-embedded tissues were stained with hematoxylin and eosin (H&E, inflammatory histology) and Masson's trichrome (fibrosis) by the University of Michigan CCGC Research Histology and Immunoperoxidase Laboratory (Ann Arbor, MI). Digital photomicrographs of tissue sections were taken with an Olympus BX microscope (University of Michigan Microscopy and Image Analysis Laboratory). Histological scoring was performed by two blinded observers (J.K., J.L.). Tissue measurements were quantitated with ImageJ analysis software.
Histological Scoring
Gastric tissue was scored for inflammation on a scale of 0 ¼ none to 3 ¼ marked by the Modified Sydney Approach. 10 Cecal inflammation was determined using a separate scoring system 11 : (0) no inflammation; (1) low level of inflammation with scattered infiltrating mononuclear cells; (2) moderate inflammation with multiple foci; (3) high level of inflammation with increased vascular density and marked wall thickening; (4) maximal severity of inflammation with transmural leukocyte infiltration and loss of goblet cells.
Immunoblotting
Immunoblotting was utilized for the detection of a-smooth muscle actin (aSMA). Whole tissue was pulverized under liquid nitrogen and lysed in ice-cold RIPA buffer with a cocktail of proteinase inhibitors (Roche, Indianapolis, IN). Protein content was determined using a modified Bradford assay kit (BioRad, Hercules, CA). Total protein was separated by sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis and transferred to PVDF membranes (Amersham Biosciences, Piscataway, NJ). Membranes were blocked in 5% milk solution for 1 hour at room temperature or overnight at 4 C. a-SMA was detected by incubating the membrane overnight at 4 C with mouse antihuman monoclonal antibody (Sigma, St. Louis, MO) at 1:5000 dilution in 5% milk/TBST. As a loading control, a mouse antibody for GAPDH (Chemicon, Temecula, CA) was used after a stripping procedure. Secondary antibody antimouse IgGþ HRP (Amersham, Piscataway, NJ) was incubated for one hour at room temperature and the signal was detected by the Pierce detection system (Rockford, IL). Autoradiographs were scanned and quantitated using Image J analysis software.
Meta-analysis
The relative risk (RR) of H. pylori infection in IBD versus controls was determined from 26 observational studies as previously described. 8 Briefly, RR was used to describe the ratio of the probability of the H. pylori infection occurring in IBD patients versus the controls. The RR was calculated with a 95% confidence interval (CI) based on a random-effects model as described by Mantel-Haenszel. 12 Meta-analysis was performed with the metan command in Stata 10.1 (StataCorp, College Station, TX).
Real-time Quantitative Polymerase Chain Reaction (PCR)
RNA was extracted from the cecum using the RNeasy kit (Qiagen, Valencia, CA). Reverse transcription of 2 lg of total RNA was performed with the Superscript FIGURE 1. H. pylori infection is negatively associated with the relative risk for developing IBD in human populations. The summary RR was calculated from 26 studies based on a random effects model. Horizontal lines delineate the upper and lower confidence limits with diamonds indicating the point estimates. The area of the gray rectangular boxes corresponds to the weight of the study in the meta-analysis. RR is shown in the right column with upper and lower 95% CIs in parentheses. The pooled RR estimate (Overall) is shown at the bottom (P < 0.0001). The solid vertical line represents no effect. 
Statistical Analysis
Comparisons between several groups of mice and associated tissues or RNA expression were analyzed with analysis of variance (ANOVA), while pairwise comparisons of two groups were performed with Student's t-test.
RESULTS
H. pylori Infection Is Negatively Associated with the RR for Developing IBD in Human Populations
An update of our previously published meta-analysis of 24 observational studies was performed to include an additional two new studies. 1 The overall RR of developing IBD in patients infected with H. pylori was 0.63 (95% CI; 0.54-0.73, P < 0.001, Fig. 1 ). This observation suggests that H. pylori infection is protective against the development of IBD.
H. pylori Infection Suppresses the Th17 Cytokine Response in the Cecum
To examine the effect of H. pylori gastric infection on distal gut inflammation, H. pylori-infected mice were coinfected with S. typhimurium. Chronic infection with S. typhimurium is characterized by a dramatic reduction in cecal size and a concurrent increase in tissue inflammation. 9 Mice infected with either S. typhimurium or coinfected with H. pylori / S. typhimurium developed marked changes in cecal appearance compared to either the uninfected or H. pylori-infected mice ( Fig. 2A) . H&E histological sections of cecal tissue from S. typhimurium or H. pylori / S. typhimurium-infected animals exhibited extensive crypt loss, inflammatory infiltration, transmural inflammation, and hypertrophy in the muscularis propria, findings that were not present in uninfected or H. pyloriinfected controls (Fig. 2B) . S. typhimurium infection elicits both innate (IL-1b and TNF-a) and adaptive (IL-12p40, IL-6, IFN-c, and IL-17) responses in the cecum (Fig. 2C-H) . H. pylori / S. typhimurium coinfection significantly repressed IL-6 and IL-17 mRNA expression (3-fold and 5.3-fold, respectively) in the cecum, with a trend toward lower IL-1b and TNF-a in the cecum compared to infection by S. typhimurium alone. As expected, H. pylori infection alone did not significantly induce these proinflammatory cytokines in the cecum except for a small but significant rise in IFN-c expression. Overall, gastric H. pylori infection significantly downregulates the cecal Th17 response to S. typhimurium infection.
H. pylori Gastric Colonization and S. typhimurium Cecal Colonization Are Not Altered by Coinfection
To examine whether H. pylori suppression of S. typhimurium colitis is caused by a reduction in the level of S. typhimurium cecal colonization, the effect of H. pylori infection upon S. typhimurium cecal colonization was determined. S. typhimurium heavily colonizes the mouse cecum, persisting at day 21 postinfection. Luminal cecal contents were isolated from uninfected, S. typhimurium, H. pylori, and H. pylori / S. typhimurium coinfected mice. Despite prior H. pylori infection, S. typhimurium cecal colonization did not differ between S. typhimurium-infected and H. pylori / S. typhimurium coinfected mice (Fig. 3 ). Therefore, H. pylori suppression of the Th17 response to S. typhimurium was not due to a decrease in S. typhimurium colonization of the cecum.
To investigate further the mechanism of H. pylori's effect on distal GI tract, we studied whether H. pylori could colonize the mouse cecum, allowing it to directly suppress local mucosal immune responses. First, levels of gastric H. pylori colonization were compared and no difference was found between H. pylori infection alone versus coinfection with S. typhimurium by qRT-PCR (Supporting Fig. 2A ). Our data also showed that H. pylori did not colonize the cecum as cecal tissue samples had undetectable levels of H. pylori urease A measured by quantitative RT-PCR from either H. pylori or H. pylori / S. typhimurium coinfected mice (Supporting Fig. 2B ).
H. pylori Infection Does Not Alter S. typhimuriuminduced Th2 or Treg Cytokine Responses in the Mouse Cecum
Another potential mechanism of immune suppression by H. pylori is by induction of Th2 or Treg responses in the cecum. H. pylori infection alone did not induce significant cecal expression of Th2 cytokines IL-4 and IL-13, but did induce higher levels of IL-10 and Foxp3 in the cecum (Fig. 4) . During coinfection with S. typhimurium, however, the H. pylori coinfection was not associated with an increased cecal IL-10 expression but a trend towards increased Foxp3 was observed (Fig. 4C,D) . H. pylori infection alone induced significant increases in the expression of IL-10 and Foxp3 in the cecum, and a mild increase in IL-13, but had no effect on IL-4 (Fig. 4A,B) . During coinfection with H. pylori and S. typhimurium, there was no further increase in cecal IL-10 and Foxp3. Addition of S. typhimurium did reverse the induction of IL-13 by H. pylori, to either monoinfection with H. pylori or S. typhimurium. These findings suggest that gastric H. pylori's immunosuppressive effect at a distance in the cecum may be related to the immunoregulatory modulation of the Th17 cecal mucosal immune response.
H. pylori Infection Induces IL-10 Expression in the Mesenteric Lymph Nodes.
To examine whether the immunoregulatory effect of H. pylori infection in the cecum also occurs in the secondary draining lymph nodes, mesenteric lymph nodes (MLNs) were collected and cytokine profiles compared. As shown in Figure 5A , H. pylori infection increased IL-10 mRNA expression in the MLNs compared to uninfected mice. During S. typhimurium infection, the levels of MLN IL-10 decreased and the levels of IL-17 and IFN-c were increased compared to uninfected mice (Fig. 5B,C) . No significant differences in these cytokine levels were measured with H. pylori / S. typhimurium coinfection, suggesting a greater influence of H. pylori infection in the cecum than in the MLNs. This could be due to the presence of H. pylori antigen traveling through the intestinal lumen and augmenting the immunoregulatory effect of H. pylori at the cecal mucosa.
H. pylori Infection Does Not Affect S. typhimurium-induced Cecal Fibrosis
Chronic S. typhimurium infection produces an intestinal fibrosis phenotype similar to human Crohn's disease. 9 Fibrosis is largely confined to the cecum and is characterized by excessive extracellular matrix deposition, submucosal hypertrophy, and myofibroblast activation. S. typhimurium infection induces a marked increase in extracellular collagen deposition as determined by trichrome staining of cecal tissue compared to uninfected or H. pylori-infected mice (Fig. 6A) . H. pylori / S. typhimurium coinfection induces a similar response. Cecal submucosal expansion, a measure of both edema and fibrosis, was induced 4.7-fold by S. typhimurium infection compared to uninfected mice (Fig.  6B ). H. pylori / S. typhimurium coinfection induced a similar 4.5-fold increase in submucosal thickness, indicating H. pylori did not alter the fibrogenic response induced by S. typhimurium (P ¼ 0.01 versus uninfected), while H. pylori infection alone had no effect. Collagen deposition is effected by activated resident myofibroblasts which express aSMA that is mediated by TGF-b during the wound-healing response. S. typhimurium induces higher aSMA protein and TGF-b mRNA expression compared to uninfected mice as determined by Western blotting (Fig. 6C,D) . H. pylori / S. typhimurium coinfection induces similar levels of aSMA protein TGF-b mRNA expression, comparable to S. typhimurium alone. Therefore, gastric H. pylori coinfection does not reduce S. typhimurium-induced intestinal fibrosis. H. pylori and S. typhimurium Coinfection Decreases Inflammation in Both the Stomach and Cecum H. pylori infection is characterized by gastric hyperplasia and inflammatory infiltration in the gastric mucosa. H&E-stained sections of stomach from H. pylori-infected mice exhibit hyperplasia and leukocyte infiltration compared to uninfected mice (Fig. 7A) . S. typhimurium infection does not induce gastritis. To assess the extent of H. pylori induced gastritis, H&E-stained sections of mouse stomach were scored by two blinded observers using the Modified Sydney Approach for inflammation. 10 Mice infected with H. pylori developed significant gastritis compared to uninfected mice (2.0 versus 0 points, P < 0.01). H. pylori / S. typhimurium coinfected mice have a lower gastritis score than H. pylori-infected mice (Fig. 7B) .
While H. pylori infection induces gastritis, H. pylori effects on the lower GI tract are unknown. H&E-stained cecal tissue sections were scored by a blinded observer on a 0 to 4 scale 11 for mononuclear infiltration, vascular density, wall thickening, transmural leukocyte infiltration, and loss of goblet cells (Fig. 7C) . Surprisingly, H. pylori infection alone induces mild cecal inflammation compared to uninfected mice (2.4 versus 3.6, P ¼ 0.0009). While mice infected with S. typhimurium (3.6 versus 0.4, P < 0.0001) or H. pylori /S. typhimurium (2.4 versus 0.4, P ¼ 0.004) developed marked cecal inflammation compared to uninfected controls, H. pylori / S. typhimurium coinfected mice exhibited less cecal inflammation than S. typhimurium-infected alone (2.4 versus 3.6, P ¼ 0.009). This indicates immunological crosstalk between the upper and lower GI tract.
DISCUSSION
The incidence of H. pylori infection is highest among individuals from developing countries and lower in developed countries. The incidence of IBD has an opposite trend, raising the possibility of immunological crosstalk between the stomach and the distal GI tract. In fact, an update of our previously published meta-analysis 8 indicates 
